Purchase Order 75N92025P00040
Award Date
12/20/24
Potential Completion Date
12/19/25
Potential Value
$35K
Federal Agency
National Heart Lung and Blood Institute
Awardee
Mission Bio, Inc.
Ultimate Awardee
Not listed
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
South San Francisco, CA 94080, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Mission Bio, Inc. was awarded a $39,880 purchase order by the National Heart, Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to deliver single-cell DNA protein reagent kits. The firm-fixed price order is for a one-year base period of performance beginning September 15, 2023 through September 14, 2024 in South San Francisco, California. The original solicitation sought single-cell DNA and protein reagent kits to support NHLBI's research efforts...
This is a $67,980 firm fixed price purchase order awarded by the National Heart, Lung and Blood Institute (NHLBI) to Mission Bio, Inc., a for-profit manufacturer of biological supplies and sequencing instruments and services. The contract is for a project titled "Clonal Evolution of Driver Mutations in Patients" and has an ultimate completion date of September 9, 2025. The award does not have a set-aside designation. Mission Bio, a company registered in the System for Award...
Mission Bio, Inc. has been awarded a firm fixed price purchase order valued at one hundred sixty-six thousand seven hundred twenty-nine dollars by the National Heart, Lung and Blood Institute (NHLBI) of the National Institutes of Health (NIH). The contract is for a project titled "Clonal Evolution of Driver Mutations" to be performed in South San Francisco, California over a one year period concluding in August 2024. As part of the NIH's efforts to advance understanding of the...
This firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) to Mission Bio, Inc., a for-profit manufacturer of biological supplies, reagent kits, sequencing instruments, and sequencing services. The $21,230 contract supports NIH's biomedical research and genomics efforts in areas such as infectious disease, hematology, oncology, and personalized medicine. Mission Bio has also received a $1.8 million National Cancer Institute grant to support measurable residual...
The National Heart, Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services (HHS), has awarded a $42,427 firm fixed price delivery order contract to Illumina, Inc. to provide reagents and kits necessary for next-generation sequencing on laboratory instruments in support of NHLBI-funded investigators. The place of performance is Illumina's facilities in San Diego, California. The period of performance is one month,...
The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a firm-fixed-price purchase order contract to Mission Bio, Inc., a for-profit manufacturer, to provide a Tapestri Single-Cell DNA Training Kit. The contract has a potential value of $162,150.00 and a completion date of January 19, 2024. This award does not have a small business set-aside designation. Mission Bio is a vendor that has previously received prime federal contract awards and...
The National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), awarded a $10,620 firm fixed price purchase order to Proteogenix, a for-profit manufacturer of biotechnology products and services. The contract provides additional laboratory screening services to support the development of novel gene therapy by the NHLBI's Center for Molecular Therapeutics and Bioanalytics (CMTB). This award is not associated with a larger contract vehicle and does not have...
The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $134,160 purchase order to Mission Bio, Inc. of South San Francisco, California. The firm fixed price order is for Mission Bio Tapestri reagents and services to support the agency's biomedical research efforts. No major subcontractors or set aside designations were indicated. Mission Bio will provide its Tapestri single-cell DNA and RNA sequencing platform reagents from June 2023 through August...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. government, awarded a $229,104 firm fixed-price purchase order contract to Psomagen Inc., a for-profit organization and manufacturer of goods. The contract, which has no set-aside designation, is for investigating transthyretin (TTR) variants and their impact on sickle cell disease severity using Olink proteomics technology. This contract is part of a larger $500 million single-award Indefinite Delivery...
The National Heart, Lung and Blood Institute (NHLBI) awarded a $70,299.26 firm fixed price delivery order to Illumina, Inc. to provide next-generation sequencing kits and reagents. The kits and reagents will support the Institute's Sequencing Core Facility in carrying out sequencing on Illumina instruments for investigators. Funding comes from the Department of Health and Human Services National Institutes of Health. Illumina will perform under the contract through September 29, 2023 with all...